Upharmacia March 2017
Terms on the requirement on
warehouses of licensees.
PATH to
P rovide
I nnovative
TB D rug to U kraine
In Apr, the international
organization PATH plans
to import innovative drug
bedaquiline for the treatment
of tuberculosis with enhanced
resistance. The drug will be
provided to Ukraine as a
donation of USAID within the
project Challenge TB.
According to the Public Health
Centre of the MOH the drug in
not registered in Ukraine yet,
but it could be registered under
the simplified procedure. The
treatment of Ukrainian patients
will be provided on the basis of
the Institute of Phthisiology and
Pulmonology n.a. F. Yanovskiy.
Bedaquiline is used in more
than 70 countries of the
world. Ukraine seeks the
opportunities to be included in
the list of countries, which have
preferences for the purchase of
the drug.
BCPP P lans
to I nvest
UAH 317 mio
in M odernization
Ukrainian company Bor-
shchahivskiy Chemical
Pharmaceutical Plant (BCPP)
plans to invest UAH 317 mio
(USD 11.7 mio) in modernization
of its production by the end of
2018.
“Despite the difficult economic
situation in the country, we
continue the implementation
of our plans and invest in our
development,” the Commercial
Director of BCPP said.
In 2016, BCPP doubled its net
income vs 2015 to UAH 118.7
mio. The company retained the
15th position on the commercial
drug market. Last year
Ukrainian company Darnitsa,
which owns about 30% of
BCPP’s shares, took measures
to acquire the company.
The Board of BCPP strongly
opposed such actions, accusing
Darnitsa of hostile takeover.
REGULATORY UPDATES
T he C abinet of M inisters of
U kraine F orces C ustomers
of D ietary S upplements
A dvertisement to “P ut the
P hone D own ”
On Mar 10, the Verkhovna Rada
of Ukraine registered the Draft
Law on amendments to article
21 of the Law of Ukraine “On
Advertising”, which proposes to
amend the rules for advertising
certain categories of goods.
In particular, changes are
aimed at stopping numerous
abuses during the advertising
of goods not related to
medicinal products, medical
products and methods
www.upharma-c.com
of prevention, diagnostic,
treatment and rehabilitation,
including advertising of dietary
supplements, food for special
dietary consumption and
functional foods.
The draft prohibits the use
of contact numbers in the
advertising of the said goods, as
well as in printed publications
and during the broadcast of
information and information
and analytical programs on
medical topics. Note that
consumers were asked to call
on such numbers for more
detailed information about
the products mentioned in the
Provided by
advertisement.
The draft allows communicating
a contact phone number in
printed media and during
medical programs if the
customer of the advertisement
is a medical institution or a
person engaged in medical
practice.
T he G overnment A pproved the
N ew N ational L ist of E ssential
D rugs
On Mar 16, Ukrainian Cabinet
7